AKUMS — Akums Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹65.21bn
- IN₹49.54bn
- IN₹41.18bn
- 87
- 54
- 19
- 56
Annual balance sheet for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 874 | 1,033 | 1,505 | 2,878 | 5,819 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,138 | 10,090 | 9,597 | 9,831 | 9,930 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,574 | 18,916 | 19,242 | 19,409 | 22,746 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9,006 | 10,439 | 11,925 | 13,772 | 15,498 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,669 | 30,690 | 32,665 | 35,164 | 41,134 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,800 | 12,724 | 12,656 | 12,106 | 8,937 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12,820 | 24,471 | 25,493 | 28,069 | 10,664 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 8,848 | 6,220 | 7,172 | 7,095 | 30,470 |
| Total Liabilities & Shareholders' Equity | 21,669 | 30,690 | 32,665 | 35,164 | 41,134 |
| Total Common Shares Outstanding |